Patents by Inventor Douglas R. Flanagan

Douglas R. Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
    Publication number: 20200297756
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Application
    Filed: June 11, 2020
    Publication date: September 24, 2020
    Inventors: Christopher KEVIL, Anthony GIORDANO, Douglas R. FLANAGAN, Panayiotis P. CONSTANTINIDES
  • PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
    Publication number: 20200085861
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Application
    Filed: October 11, 2019
    Publication date: March 19, 2020
    Inventors: Christopher KEVIL, Anthony GIORDANO, Douglas R. FLANAGAN, Panayiotis P. CONSTANTINIDES
  • Pharmaceutical formulations of nitrite and uses thereof
    Patent number: 10463689
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: November 5, 2019
    Assignee: Board of Supervisors of Louisiana State University
    Inventors: Christopher Kevil, Anthony Giordano, Douglas R. Flanagan, Panayiotis P. Constantinides
  • Pharmaceutical formulations of nitrite and uses thereof
    Patent number: 10307441
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: June 4, 2019
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Christopher Kevil, Anthony Giordano, Douglas R Flanagan, Panayiotis P Constantinides
  • PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
    Publication number: 20160067279
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Christopher Kevil, Anthony Giordano, Douglas R. Flanagan, Panayiotis P. Constantinides
  • Sustained release parenteral formulations of buprenorphine
    Patent number: 8455508
    Abstract: An oil-in-water buprenorphine formulation including buprenorphine and a surfactant that emulsifies the buprenorphine in oil, wherein the drug release is controlled by varying the oil concentration and/or pH. A buprenorphine aqueous suspension formulation including a free base buprenorphine and a suspension stabilizer. A buprenorphine oil formulation including a buprenorphine salt suspended in a pharmaceutically acceptable oil. Methods of providing sustained release of buprenorphine over a period of time.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: June 4, 2013
    Assignee: Abbott Laboratories
    Inventors: Carmela Luangdilok, Douglas R. Flanagan, Luk-Chiu Li, Matthew Widman
  • PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
    Publication number: 20110086069
    Abstract: The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO2?). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
    Type: Application
    Filed: October 14, 2010
    Publication date: April 14, 2011
    Applicant: TheraVasc, LLC
    Inventors: Christopher KEVIL, Anthony GIORDANO, Douglas R. FLANAGAN, Panayiotis P. CONSTANTINIDES
  • SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE
    Publication number: 20100093778
    Abstract: An oil-in-water buprenorphine formulation including buprenorphine and a surfactant that emulsifies the buprenorphine in oil, wherein the drug release is controlled by varying the oil concentration and/or pH. A buprenorphine aqueous suspension formulation including a free base buprenorphine and a suspension stabilizer. A buprenorphine oil formulation including a buprenorphine salt suspended in a pharmaceutically acceptable oil. Methods of providing sustained release of buprenorphine over a period of time.
    Type: Application
    Filed: December 11, 2009
    Publication date: April 15, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Carmela Luangdilok, Douglas R. Flanagan, Luk-Chiu Li, Matthew Widman
  • SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE
    Publication number: 20080227805
    Abstract: An oil-in-water buprenorphine formulation including buprenorphine and a surfactant that emulsifies the buprenorphine in oil, wherein the drug release is controlled by varying the oil concentration and/or pH. A buprenorphine aqueous suspension formulation including a free base buprenorphine and a suspension stabilizer. A buprenorphine oil formulation including a buprenorphine salt suspended in a pharmaceutically acceptable oil. Methods of providing sustained release of buprenorphine over a period of time.
    Type: Application
    Filed: February 28, 2008
    Publication date: September 18, 2008
    Applicant: Abbott Laboratories
    Inventors: Carmela Luangdilok, Douglas R. Flanagan, Luk-Chiu Li, Matthew Widman
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20020155066
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: February 4, 2002
    Publication date: October 24, 2002
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Patent number: 6348209
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: February 19, 2002
    Assignee: Battelle Pulmonary Therapeutics, Inc.
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Jr., Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010038826
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010038827
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010036444
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 1, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan